View in EDS

Enhancing immunotherapy with tumour-responsive nanomaterials.

Saved in:
Bibliographic Details
Title: Enhancing immunotherapy with tumour-responsive nanomaterials.
Authors: Linderman SW; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Hospital Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA., DeRidder L; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard-MIT Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, MA, USA., Sanjurjo L; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain., Foote MB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alonso MJ; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.; Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain.; IMDEA Nanosciences Institute, Madrid, Spain., Kirtane AR; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA., Langer R; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. rlanger@mit.edu.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. rlanger@mit.edu., Traverso G; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. cgt20@mit.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. cgt20@mit.edu.
Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2025 Apr; Vol. 22 (4), pp. 262-282. Date of Electronic Publication: 2025 Mar 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40050505
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Enhancing immunotherapy with tumour-responsive nanomaterials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Linderman+SW%22">Linderman SW</searchLink>; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Hospital Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22DeRidder+L%22">DeRidder L</searchLink>; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard-MIT Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sanjurjo+L%22">Sanjurjo L</searchLink>; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Foote+MB%22">Foote MB</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Alonso+MJ%22">Alonso MJ</searchLink>; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.; Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain.; IMDEA Nanosciences Institute, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Kirtane+AR%22">Kirtane AR</searchLink>; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Langer+R%22">Langer R</searchLink>; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. rlanger@mit.edu.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. rlanger@mit.edu.<br /><searchLink fieldCode="AU" term="%22Traverso+G%22">Traverso G</searchLink>; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. cgt20@mit.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. cgt20@mit.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101500077%22">Nature reviews. Clinical oncology</searchLink> [Nat Rev Clin Oncol] 2025 Apr; Vol. 22 (4), pp. 262-282. <i>Date of Electronic Publication: </i>2025 Mar 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101500077 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1759-4782 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217594774%22">17594774 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40050505
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41571-025-01000-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 262
    Titles:
      – TitleFull: Enhancing immunotherapy with tumour-responsive nanomaterials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Linderman SW
      – PersonEntity:
          Name:
            NameFull: DeRidder L
      – PersonEntity:
          Name:
            NameFull: Sanjurjo L
      – PersonEntity:
          Name:
            NameFull: Foote MB
      – PersonEntity:
          Name:
            NameFull: Alonso MJ
      – PersonEntity:
          Name:
            NameFull: Kirtane AR
      – PersonEntity:
          Name:
            NameFull: Langer R
      – PersonEntity:
          Name:
            NameFull: Traverso G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2025 Apr
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1759-4782
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Nature reviews. Clinical oncology
              Type: main
ResultId 1